These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26033540)

  • 1. Steered molecular dynamics approach for promising drugs for influenza A virus targeting M2 channel proteins.
    Nguyen H; Le L
    Eur Biophys J; 2015 Sep; 44(6):447-55. PubMed ID: 26033540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the free energy profiles of amantadine and rimantadine in the AM2 binding pocket.
    Van Nguyen H; Nguyen HT; Le LT
    Eur Biophys J; 2016 Jan; 45(1):63-70. PubMed ID: 26391902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does influenza virus a escape from amantadine?
    Qin G; Yu K; Shi T; Luo C; Li G; Zhu W; Jiang H
    J Phys Chem B; 2010 Jul; 114(25):8487-93. PubMed ID: 20521806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
    Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N/L26I and M2-S31N/V27A from the influenza A viruses.
    Musharrafieh R; Ma C; Wang J
    Eur J Pharm Sci; 2020 Jan; 141():105124. PubMed ID: 31669761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers.
    Cady SD; Schmidt-Rohr K; Wang J; Soto CS; Degrado WF; Hong M
    Nature; 2010 Feb; 463(7281):689-92. PubMed ID: 20130653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel.
    Arns S; Balgi AD; Shimizu Y; Pfeifer TA; Kumar N; Shidmoossavee FS; Sun S; Tai SS; Agafitei O; Jaquith JB; Bourque E; Niikura M; Roberge M
    Eur J Med Chem; 2016 Sep; 120():64-73. PubMed ID: 27187859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening and molecular growth guide the design of inhibitors for the influenza virus drug-resistant mutant M2-V27A/S31N.
    Deng C; Wang X; Wang T; Liu W; Yuan X; Huang Y; Cao S
    J Biomol Struct Dyn; 2024 Jul; 42(10):5253-5267. PubMed ID: 37424098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
    Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
    Du QS; Huang RB; Wang SQ; Chou KC
    PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.
    Duque MD; Ma C; Torres E; Wang J; Naesens L; Juárez-Jiménez J; Camps P; Luque FJ; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
    J Med Chem; 2011 Apr; 54(8):2646-57. PubMed ID: 21466220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance-Mutation (N31) Effects on Drug Orientation and Channel Hydration in Amantadine-Bound Influenza A M2.
    Gleed ML; Ioannidis H; Kolocouris A; Busath DD
    J Phys Chem B; 2015 Sep; 119(35):11548-59. PubMed ID: 26268449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Broad-Spectrum Inhibitors of Influenza A Virus M2 Proton Channels: A Molecular Modeling Approach.
    Klimochkin YN; Shiryaev VA; Petrov PV; Radchenko EV; Palyulin VA; Zefirov NS
    Curr Comput Aided Drug Des; 2016; 12(2):154-64. PubMed ID: 27146707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.
    Ma C; Zhang J; Wang J
    Mol Pharmacol; 2016 Sep; 90(3):188-98. PubMed ID: 27385729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.
    Wang J; Ma C; Fiorin G; Carnevale V; Wang T; Hu F; Lamb RA; Pinto LH; Hong M; Klein ML; DeGrado WF
    J Am Chem Soc; 2011 Aug; 133(32):12834-41. PubMed ID: 21744829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
    Gu RX; Liu LA; Wei DQ
    Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting Thermodynamic Profiles of Aminoadamantane Compounds Inhibiting the M2 Proton Channel of Influenza A by Free Energy Calculations.
    Homeyer N; Ioannidis H; Kolarov F; Gauglitz G; Zikos C; Kolocouris A; Gohlke H
    J Chem Inf Model; 2016 Jan; 56(1):110-26. PubMed ID: 26690735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.